Manuel B. Garcia

Manuel B. Garcia serves as the Senior Director for Educational Technology and Digital Learning at FEU Institute of Technology, Manila, Philippines. Read More

Contact Info

1607, FEU Tech Building,
P. Paredes St, Sampaloc,
Manila, Philippines
mbgarcia@feutech.edu.ph

Follow Me

Can Participants Withdraw Their Data After Analysis Has Begun?

Beginning data analysis does not create a universal point after which participant data can never be withdrawn. Whether removal remains possible depends on the regulatory framework, consent terms, data identifiability, and how far the data have already been incorporated into analyses or derived results.

137
Withdrawing Data After Analysis Begins Guide 137 of 398
01 · The Question

Is It Too Late to Withdraw Data Once Researchers Start Analyzing Them?

A participant withdraws and asks for their information to be removed. The research team has not published anything yet, but data analysis has already started. Perhaps the participant's responses are in a statistical model, their interview has been coded into themes, or their measurements have contributed to calculated variables.

Has the participant missed the opportunity to withdraw their data simply because someone clicked “Run” in the analysis software?

Not necessarily. There is no universal rule that beginning analysis instantly makes withdrawal impossible. But the further information moves into analysis, derived datasets, pooled results, and completed outputs, the more constrained removal can become. Regulatory requirements can also require retention regardless of technical feasibility.

02 · The Short Answer

Starting Analysis Is Not a Universal Cutoff

In Brief

Participants may sometimes be able to have their data excluded after analysis has begun, but there is no universal right to removal at that stage and no universal rule that analysis automatically makes removal impossible.

The answer depends on the governing regulatory framework, what participants were told about withdrawal, whether the data remain identifiable, whether removal is technically and scientifically feasible, and whether the information has already been incorporated into completed analyses, shared datasets, or research outputs.

03 · What You Need to Know

“Analysis Has Begun” Covers Many Very Different Stages

There Is No Single Moment Called “Analysis”

Research analysis is a process, not one event. In quantitative research, it can include data cleaning, recoding, constructing variables, descriptive analysis, model fitting, sensitivity analysis, and generation of final tables. In qualitative research, it may include transcription, coding, memo writing, category development, theme construction, and interpretation.

A participant requesting withdrawal while their identifiable questionnaire is still one row in an early working dataset presents a different practical problem from someone requesting withdrawal after their data have contributed to a finalized pooled estimate or completed thematic framework.

Stage What may still exist Why withdrawal may differ
Data cleaning Participant-level records remain readily identifiable or linkable Technical exclusion may still be relatively straightforward if permitted
Preliminary analysis Records have entered descriptive statistics, codes, or early models Analysis may need to be rerun if exclusion is permitted
Advanced analysis Data contribute to multiple models, themes, derived variables, or integrated datasets Removal can become more complex and consequential
Completed analysis Final results or derived outputs already exist Some frameworks and guidance recognize that completed analyses ordinarily will not be undone
Published or publicly disseminated results Information has entered the scholarly record Withdrawal raises a different set of practical and research-integrity questions

OHRP Does Not Make the Start of Analysis a Withdrawal Cutoff

OHRP's withdrawal guidance does not establish a rule saying that participant data become irrevocable as soon as analysis begins. Instead, OHRP interprets HHS regulations as allowing investigators to retain and analyze data already collected before withdrawal when the analysis remains within the IRB-approved protocol.

Importantly, OHRP also states that investigators in research not subject to FDA regulation can choose to honor a participant's request to destroy previously collected data or exclude them from analysis.

This means that, under this framework, the mere fact that analysis has started does not by itself answer whether exclusion is possible. Researchers must consider the approved protocol, consent commitments, data status, scientific consequences, and any other applicable requirements.

FDA-Regulated Trial Data Are Different

FDA policy creates a clearer retention requirement. Data already accrued in an FDA-regulated clinical trial must remain part of the study data when a participant discontinues participation. FDA links this requirement to the integrity and completeness of evidence used to assess safety and effectiveness.

Therefore, even if removing the participant's observations from an early statistical analysis would be technically easy, researchers should not do so if FDA requirements mandate retention of those accrued trial data.

Technically removable The research team can still identify the participant's data and could computationally exclude or delete them.
Permissible to remove The study's regulatory, ethics, consent, privacy, scientific-integrity, and governance requirements allow the data to be removed or excluded.

Those are not the same question. A dataset can be easy to edit while regulations require retention. Conversely, removal may be permitted in principle but technically difficult because the participant's contribution has already been transformed or integrated.

Completed Analysis Creates a More Substantial Limit

SACHRP guidance concerning stored biospecimens and associated data states that analyses already completed generally will not be destroyed or removed from datasets when a participant later withdraws. It recommends explaining these practical limitations during consent.

This does not create a universal definition of the exact moment an analysis becomes “completed.” Rather, it recognizes that withdrawal cannot always operate retrospectively on research work already performed.

The more appropriate question is therefore not merely whether analysis has started, but what has already been done with the participant's information and what can still be meaningfully changed.

Removing Raw Data May Not Remove Everything Derived From Them

Once analysis begins, a participant's information may generate other information. A raw measurement may contribute to a standardized score. Several survey items may be combined into a scale. An interview passage may influence a qualitative code, which then contributes to a broader theme.

Deleting the original record does not necessarily erase every derived result that depended on it. Researchers may need to determine whether analyses should be rerun, derived variables regenerated, qualitative interpretations reconsidered, or existing outputs retained.

This is partly why withdrawal should be governed by a documented data-management procedure rather than an improvised deletion from the master dataset.

Identifiability May Matter More Than Analytic Stage

A participant's data may be easy to remove late in analysis if the information remains linked to a participant identifier. Conversely, individual withdrawal may become impossible early if the data have already been irreversibly anonymized.

If the research team can no longer identify which observations belong to the participant, the problem is no longer simply one of rerunning an analysis. It becomes the separate question of whether anonymized data can still be withdrawn.

Analysis Can Also Involve Shared Data

A multi-site project may distribute an analysis dataset to collaborating institutions. A repository may already have released information to approved secondary users. Removing the participant's data from the originating institution's copy does not necessarily remove every authorized copy elsewhere.

SACHRP recognizes this limitation in the context of stored data and biospecimens, noting that withdrawal generally does not require retrieving material already distributed to secondary users and that completed analyses ordinarily will not be destroyed.

Researchers should therefore inventory where the data have gone before telling a participant that withdrawal from analysis can or cannot be implemented.

Scientific Integrity Is a Legitimate Consideration, but Not a Magic Phrase

Removing observations after analysis begins can alter estimates, statistical power, missing-data patterns, qualitative interpretations, or the reproducibility of previous analytic decisions. In regulated clinical trials, these concerns contribute to explicit data-retention requirements.

But researchers should not invoke “research integrity” automatically whenever deletion is inconvenient. OHRP expressly allows investigators in some non-FDA-regulated research to honor requests for destruction or exclusion. The actual regulatory and scientific context must be examined.

Consent Language Should Describe Realistic Withdrawal Limits

If a study intends to permit withdrawal only until anonymization, only before data are shared, or only before a specified stage of analysis where ethically and legally appropriate, participants should be told clearly what those limitations mean.

Likewise, researchers should avoid saying “your data can be withdrawn at any time” if the study design makes that promise impossible once certain processing occurs.

The broader issue is how participant data are handled after withdrawal. Analysis status is one part of that data lifecycle rather than an independent rule.

Watch Out

Do not create an arbitrary internal rule such as “once analysis begins, no data can ever be withdrawn” unless that limitation genuinely follows from the applicable framework and was appropriately incorporated into the study. The beginning of analysis is not, by itself, a universal ethical or regulatory point of no return.

04 · A Practical Example

A Withdrawal Request During Preliminary Analysis

Hypothetical Example

The Regression Has Been Run, but the Study Is Far From Finished

Imagine a non-FDA-regulated observational study involving 500 participants. The team has cleaned the data and run preliminary regression models. One participant then withdraws and asks for their identifiable data to be excluded from further analysis.

Identify the data The participant's record remains coded but linkable, so the research team can determine which observations belong to them.
Check the consent and protocol The team reviews what participants were told about withdrawal, the approved data-management procedure, and any ethics or institutional requirements.
Check the regulatory framework Because the study is not FDA-regulated, there is no FDA requirement that the accrued data remain in a clinical-trial database.
Assess analytic consequences The team determines that the preliminary models can be rerun without the participant's record and that no completed or disseminated results depend irreversibly on the record.
Apply the approved decision If the study's approved withdrawal procedure permits exclusion, the record is handled accordingly and the relevant analyses are rerun and documented.

The fact that preliminary analysis had already occurred did not automatically settle the request. The answer depended on the research framework, the consent commitments, identifiability, and the actual stage of analysis.

05 · What Researchers Often Get Wrong

Common Mistakes About Withdrawal During Data Analysis

Misconception

Once Analysis Starts, Is Withdrawal Automatically Impossible?

No. OHRP does not establish the beginning of analysis as a universal cutoff, and in non-FDA-regulated research investigators may sometimes honor requests to destroy or exclude previously collected data.

Misconception

If Data Can Technically Be Deleted, Must Researchers Delete Them?

No. Technical feasibility does not establish a participant's regulatory entitlement to removal. FDA-regulated trial data, for example, must remain even when deletion would be computationally straightforward.

Misconception

Is Running One Statistical Test the Point of No Return?

No. Analysis is a continuum. Preliminary calculations, exploratory analyses, finalized models, aggregate results, and completed published analyses present different practical circumstances.

Misconception

If the Raw Record Is Deleted, Does Every Analytic Contribution Disappear?

Not necessarily. The record may already have contributed to derived variables, summary statistics, qualitative codes, models, or other outputs. Researchers need to determine what else would need to change if exclusion is permitted.

Misconception

Can Researchers Refuse Every Request by Saying Removal Would Affect Research Integrity?

No. Research integrity is a legitimate consideration, but the governing framework matters. OHRP expressly recognizes that investigators in some non-FDA research may choose to destroy or exclude previously collected data at a participant's request.

06 · What This Means for You

Locate the Data in the Research Lifecycle Before Answering

When a withdrawal request arrives during analysis, identify exactly what has happened to the participant's information. “Analysis started” is too vague to support a defensible decision.

A simple decision framework

If the data remain identifiable and analysis is preliminary
Determine whether exclusion is permitted under the protocol, consent, regulatory framework, and data-management plan, and whether affected analyses should be rerun.
If the research is FDA-regulated
Retain already-accrued trial data as required, regardless of whether removal from an analysis would be technically easy.
If analyses involving the data have already been completed
Determine whether those completed analyses remain appropriately retained under the applicable framework rather than assuming they must be undone.
If the data have been irreversibly anonymized
Individual exclusion may no longer be technically possible because the participant's observations cannot be identified.
If data or analytic datasets have already been shared
Determine what withdrawal can still affect and whether previously distributed copies or completed analyses fall outside what can practically be recalled.
07 · A Quick Checklist

When a Withdrawal Request Arrives During Analysis

Before removing or retaining the data, check:
Identify the exact effective date and scope of the participant's withdrawal request.
Determine whether the participant's data remain identifiable or linkable.
Identify which analyses have begun, which are preliminary, and which have been completed.
Determine whether the data have generated derived variables, qualitative codes, aggregate statistics, or other analytic products.
Check whether any copies or analysis datasets have already been distributed to collaborators or secondary users.
Review what the participant was told about withdrawal after analysis begins.
Determine whether FDA or another applicable framework requires retention of the accrued data.
If exclusion is permitted, document whether analyses, derived datasets, or results must be regenerated.
08 · Frequently Asked Questions

Questions About Withdrawing Data During Analysis

Is there a universal cutoff once statistical analysis begins?

No. OHRP does not establish the start of analysis as a universal cutoff. Whether previously collected data can be excluded depends on the applicable framework, consent commitments, study procedures, and data status.

Can researchers rerun an analysis without the withdrawing participant?

Technically, often yes when participant-level data remain identifiable. Whether researchers should or may do so depends on the regulatory framework, approved protocol, consent terms, scientific consequences, and study stage.

What if the analysis is already complete?

Withdrawal becomes more constrained. SACHRP notes that analyses already completed generally will not be destroyed or removed from datasets. The exact handling should follow the applicable regulatory and consent framework.

Can data be removed from an FDA-regulated clinical trial during analysis?

Already-accrued trial data must remain part of the study data under FDA policy, even after the participant stops participating. The retention requirement therefore applies regardless of whether analysis is preliminary or advanced.

What if the participant's data have already contributed to a calculated score?

Removing the raw record may not automatically remove derived information. If exclusion is permitted, researchers should determine whether derived variables, models, summaries, or other outputs need to be regenerated.

What if the data were anonymized before the withdrawal request?

If researchers can no longer identify which observations belong to the participant, individual removal may no longer be technically possible. That is an anonymization issue rather than a consequence of analysis alone.

What if the research has already been published?

Publication introduces a further stage because findings have entered the scholarly record and may have been copied, indexed, cited, or incorporated into other work. Withdrawal after publication therefore requires a separate analysis of what can realistically and appropriately be changed.

09 · The Bottom Line

Analysis Beginning Is Not Automatically the Point of No Return

The Bottom Line

Participants may sometimes be able to have identifiable data excluded after analysis has begun, but the start of analysis is neither a universal guarantee of withdrawal nor a universal cutoff that makes withdrawal impossible.

Determine what the applicable regulatory framework requires, what participants were promised, whether their data remain identifiable, and how far those data have progressed into analyses, derived results, shared datasets, or completed work. FDA-regulated trial data must remain, while some non-FDA research may permit exclusion even after preliminary analysis has started.

10 · Sources and Further Reading

Authoritative Guidance and Further Reading

11 · Cite this Guide

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.

Has the Field Guide helped your research?

If a guide helped clarify a question, inform a research decision, or move your work forward, I would love to hear about your experience. Your story may also help other researchers discover the Field Guide.

Share Your Experience
Takes only a few minutes